Vancouver, British Columbia--(Newsfile Corp. - February 11, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce it intends to complete a non-brokered private placement (the "Offering") of up to 7,500,000 units (each, "Unit") at a price of $0.05 per Unit for aggregate gross proceeds of up to $375,000.
Each Unit will consist of one common share in the capital of the Company (a "Share") and one common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder thereof to purchase one Share at a price of $0.075 per Share for a period of 24 months from the date of issuance.
The securities offered pursuant to the Offering will be subject to a statutory hold period of four months and a day from the date of issuance. Finder's fees may be payable in connection with the Offering, all in accordance with the policies of the Canadian Securities Exchange.
The Company intends to use the net proceeds of the Offering to settle outstanding debt and for general and administrative expenses.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
On behalf of the Board of Directors
Daniel Liu, Chief Executive Officer
Email: daniel@republictech.io
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.
Forward-Looking Information
This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation (collectively, "forward-looking statements"). The forward-looking statements herein are made as of the date of this press release only, and the Company does not assume any obligation to update or revise them to reflect new information, estimates or opinions, future events or results or otherwise, except as required by applicable law. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budgets", "scheduled", "estimates", "forecasts", "predicts", "projects", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. These forward-looking statements include, among other things, statements relating to: the completion of the Offering, the terms of the Offering and the anticipated use of proceeds of the Offering.
Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will complete the Offering on the terms and conditions expected, that the Company will receive all necessary approvals for the Offering and that the Company will use the proceeds of the Offering as currently anticipated. Additionally, forward-looking statements involve a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of the Company to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not receive all necessary approvals for the completion of the Offering, that the Company will fail to complete the Offering on the terms disclosed, or at all, that the Company will not use the proceeds of the Offering as currently anticipated, market volatility, the state of the financial markets for the Company's securities, and political, legal and regulatory risks generally.
The forward-looking statements contained in this press release represent management's best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this press release. Neither the Company nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this press release by you or any of your representatives or for omissions from the information in this press release.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240392
SOURCE: Beyond Medical Technologies Inc.
